000242621 001__ 242621
000242621 005__ 20230208174135.0
000242621 0247_ $$2CORDIS$$aG:(EU-Grant)951723$$d951723
000242621 0247_ $$2CORDIS$$aG:(EU-Call)H2020-WIDESPREAD-2018-2020-6$$dH2020-WIDESPREAD-2018-2020-6
000242621 0247_ $$2originalID$$acorda__h2020::951723
000242621 035__ $$aG:(EU-Grant)951723
000242621 150__ $$aMolecular Bioengineering in health ERA chair$$y2021-01-01 - 2026-06-30
000242621 372__ $$aH2020-WIDESPREAD-2018-2020-6$$s2021-01-01$$t2026-06-30
000242621 450__ $$aMOBILIsE$$wd$$y2021-01-01 - 2026-06-30
000242621 5101_ $$0I:(DE-588b)5098525-5$$2CORDIS$$aEuropean Union
000242621 680__ $$aMOBILIsE aims to recruit an outstanding Researcher to act as the ERA Chair Holder to the National Institute of Biomedical Engineering (INEB). She/he will establish a new research direction in Molecular Bioengineering focused on precision medicine, namely in targeted therapies and molecular diagnosis, and create a synergic and cohesive research environment among key stakeholders (academy, research institutes, clinicians and industry) in the Porto region: the MOBILIsE hub. The MOBILIsE project will boost the translation of the design of new molecular targets to the application of diagnostic tools and therapies targeted to the major health challenges, with particular focus on cancer, infection, neurodegenerative diseases, and tissue repair/regeneration that have been explored at the institute. INEB is already recognized for its fundamental work in protein/cell-materials interactions and in the development of nanotechnology tools for targeted controlled drug delivery. Yet, the potential and projection at international level of cross-disciplinary research, like the application of nanomedicine to cancer and neurologic disorders, is still limited. This has a major impact on funding attraction, transfer of technology, and translational potential of the research developed. Hence, this project will hire an expert in Molecular Bioengineering to install an internationally competitive research group focused on precision medicine. The group will exploit nanotechnology tools to discover new molecular targets that can be explored in the design of new diagnostic and/or therapeutic systems. The MOBILIsE project will promote the integration between biomedical engineering, biology and medicine, by focusing on (vital) interactions at the molecular level with impact on human health. Ultimately, MOBILIsE aims to establish a Molecular Bioengineering research group that will facilitate critical institutional structural changes to maximize the high potential for research excellence at INEB.
000242621 909CO $$ooai:juser.fz-juelich.de:899061$$pauthority$$pauthority:GRANT
000242621 909CO $$ooai:juser.fz-juelich.de:899061
000242621 980__ $$aG
000242621 980__ $$aCORDIS
000242621 980__ $$aAUTHORITY